Massive barcode-free chemical screenings enable the discovery of bioactive macrocycles with passive membrane permeability
Authors:
- J. Miguel MataJMJ. Miguel Mata
- Sean M. McKennaSMSean M. McKenna
- Edith van der NolENEdith van der Nol
- Marije HavermansMHMarije Havermans
- Ruud DelwelRDRuud Delwel
- Mike FiliusMFMike Filius
- Chirlmin JooCJChirlmin Joo
- Maura VallaroMVMaura Vallaro
- Giulia CaronGiulia Caron
- Sebastian J. PomplunSPSebastian J. Pomplun
Open Access
- 10 April 2026
- journal article
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Abstract
Synthetic macrocycles offer exceptional potential as therapeutics. However, most high-throughput discovery platforms rely on genetically encoded libraries of large peptide macrocycles, which typically are not optimized for drug like properties. Fully synthetic libraries offer greater flexibility in accessing broader chemical space. Leveraging recent advances in mass spectrometry based library techniques, here we report CycloSEL (Cyclic Self-Encoded Libraries), an end-to-end workflow, that screens synthetic macrocycle libraries enriched in drug-like ‘beyond rule of five’ features. The workflow relies on affinity selections and hit identification by tandem mass spectrometry, eliminating the need for genetic barcodes. We construct a 16 million-member library and validate the approach against the oncology target carbonic anhydrase IX, achieving robust enrichment and accurate identification of true binders. Applying CycloSEL to the acute myeloid leukemia target WD repeat-containing protein 5 (WDR5) yields a macrocycle with subnamolar affinity, and potent inhibition of the WDR5–Mixed-Lineage Leukemia 1 (MLL1) interaction. Subsequent modifications produce a chameleonic macrocycle with passive membrane permeability, serum stability, and anti-proliferative activity in leukemia cells. Together, these results demonstrate that CycloSEL enables discovery of drug-like macrocycles from fully synthetic libraries for intracellular targets.Keywords
Funding Information
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek (OCENW.M.21.157)
- Horizon 2020 Framework Programme (101039354)
- C.J. was supported by the Ministry of Science and ICT, Korea
This publication has 62 references indexed in Scilit:
- A Tag‐Free Platform for Synthesis and Screening of Cyclic Peptide LibrariesAngewandte Chemie, 2024
- Cyclic Peptides for Drug DevelopmentAngewandte Chemie International Edition, 2023
- Identification of a PCSK9-LDLR disruptor peptide with in vivo functionCell Chemical Biology, 2022
- Targeting intracellular protein–protein interactions with macrocyclic peptidesTrends in Pharmacological Sciences, 2021
- The 2018 Nobel Prize in Chemistry: phage display of peptides and antibodiesAnalytical and Bioanalytical Chemistry, 2019
- Quantifying the chameleonic properties of macrocycles and other high-molecular-weight drugsDrug Discovery Today, 2016
- Interaction with WDR5 Promotes Target Gene Recognition and Tumorigenesis by MYCMolecular Cell, 2015
- A Novel Design of Artificial Membrane for Improving the PAMPA ModelPharmaceutical Research, 2008
- Functional reconstruction and synthetic mimicry of a conformational epitope using CLIPS™ technologyJournal of Molecular Recognition, 2007
- PEAKS: powerful software for peptide de novo sequencing by tandem mass spectrometryRapid Communications in Mass Spectrometry, 2003